Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Saul Brusilow0
Pamela L. Zeitlin0
Date of Patent
July 7, 2009
Patent Application Number
09523776
Date Filed
March 11, 2000
Patent Primary Examiner
Patent abstract
The present invention generally relates to diseases or conditions modulated by undesired protein expression. In one aspect, the methods provide for administration to a mammal, particularly a human, of a therapeutically effective amount of a carbocyclic aryl compound capable of modulating that undesired protein expression. Assays for detecting compounds having desired therapeutic capacity are also provided.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
